PDF(Pubmed)
Abstract：
UNASSIGNED: Implantation of multifocal intraocular lenses (IOLs) is becoming increasingly popular for the treatment of visual demands at various distances in patients undergoing phacoemulsification cataract surgery. We aimed to assess the visual performance and rates of photic phenomena, posterior capsule opacification (PCO), and spectacle independence in patients with bilateral implantation of the AcrySof® IQ PanOptix® multifocal IOL model TFNT00 at one and six months postoperatively.
UNASSIGNED: This prospective interventional cohort study included adult patients who underwent uneventful phacoemulsification cataract surgery with bilateral implantation of AcrySof® IQ PanOptix® IOL. Uncorrected and corrected visual acuities at far, intermediate, and near distances were measured preoperatively and at the one- and six-month postoperative follow-up examinations. The rates of photic phenomena, postoperative need for near and distance spectacles, and PCO were also recorded.
UNASSIGNED: We included 164 eyes of 82 patients with a male-to-female ratio of 38 (46.3%) to 44 (53.7%) and a mean (standard deviation [SD]) age of 52.37 (7.62) years. There were statistically significant improvements in the visual acuities of both eyes across all distances at the one- and six-month follow-up examinations compared to the preoperative values (all P < 0.001), except for corrected near visual acuity in the right eye (P > 0.05) at six-month. We also detected significant postoperative improvements in visual acuities of both eyes across all distances at the six-month follow-up compared to values at the one-month follow-up (all P < 0.05), except for corrected near visual acuity in the right eye (P > 0.05). The photic phenomenon was reported by 12 (14.6%) of the 82 patients at the six-month postoperative follow-up. Five (6.1%) and eight (9.8%) of the 82 patients reported using spectacles for distance and near, respectively. Additionally, PCO developed in 19 (11.6%) of the 164 included eyes, although it was not clinically significant at six months.
UNASSIGNED: The AcrySof® IQ PanOptix® IOL model TFNT00 is recommended for use, given its excellent performance in all ranges of vision, a high rate of spectacle independence, and a good safety profile. Future comparative studies with longer follow-up periods are warranted to verify superiority of its performance over that of other available multifocal IOLs.
UNASSIGNED: This prospective interventional cohort study included adult patients who underwent uneventful phacoemulsification cataract surgery with bilateral implantation of AcrySof® IQ PanOptix® IOL. Uncorrected and corrected visual acuities at far, intermediate, and near distances were measured preoperatively and at the one- and six-month postoperative follow-up examinations. The rates of photic phenomena, postoperative need for near and distance spectacles, and PCO were also recorded.
UNASSIGNED: We included 164 eyes of 82 patients with a male-to-female ratio of 38 (46.3%) to 44 (53.7%) and a mean (standard deviation [SD]) age of 52.37 (7.62) years. There were statistically significant improvements in the visual acuities of both eyes across all distances at the one- and six-month follow-up examinations compared to the preoperative values (all P < 0.001), except for corrected near visual acuity in the right eye (P > 0.05) at six-month. We also detected significant postoperative improvements in visual acuities of both eyes across all distances at the six-month follow-up compared to values at the one-month follow-up (all P < 0.05), except for corrected near visual acuity in the right eye (P > 0.05). The photic phenomenon was reported by 12 (14.6%) of the 82 patients at the six-month postoperative follow-up. Five (6.1%) and eight (9.8%) of the 82 patients reported using spectacles for distance and near, respectively. Additionally, PCO developed in 19 (11.6%) of the 164 included eyes, although it was not clinically significant at six months.
UNASSIGNED: The AcrySof® IQ PanOptix® IOL model TFNT00 is recommended for use, given its excellent performance in all ranges of vision, a high rate of spectacle independence, and a good safety profile. Future comparative studies with longer follow-up periods are warranted to verify superiority of its performance over that of other available multifocal IOLs.
摘要：
■多焦点人工晶状体(IOL)的植入在接受超声乳化白内障手术的患者的各种距离的视觉需求的治疗中变得越来越流行。我们的目的是评估光现象的视觉表现和比率，后囊混浊（PCO），术后1个月和6个月双侧植入AcrySof®IQPanOptix®多灶性IOL模型TFNT00的患者的眼镜独立性。
■这项前瞻性干预队列研究包括接受了顺利的白内障超声乳化手术并双侧植入AcrySof®IQPanOptix®IOL的成年患者。远未矫正视力和矫正视力，中间,在术前和术后1个月和6个月的随访检查中测量了近距离.光现象的速率，术后需要近距离和远距离眼镜，和PCO也被记录。
■我们纳入了82例患者的164只眼，男女比例为38（46.3％）至44（53.7％），平均（标准差[SD]）年龄为52.37（7.62）岁。在1个月和6个月的随访检查中，所有距离的双眼视力与术前值相比均有统计学上的显着改善（均P<0.001），除了6个月时右眼矫正近视力(P>0.05)。我们还发现，与一个月随访时相比，在六个月随访时，双眼在所有距离上的术后视力均有显着改善（均P<0.05）。除右眼矫正近视力外(P>0.05)。在术后6个月的随访中，82例患者中有12例（14.6％）报告了光现象。82例患者中有5例（6.1％）和8例（9.8％）报告使用眼镜进行远距离和近距离，分别。此外,在164只被收录的眼睛中，有19只(11.6%)开发了PCO，尽管在6个月时没有临床意义。
■建议使用AcrySof®IQPanOptix®IOL型号TFNT00，鉴于其在所有视觉范围内的出色性能，高的眼镜独立性，和良好的安全性。未来的比较研究需要更长的随访时间，以验证其性能优于其他可用的多焦点IOL。
■这项前瞻性干预队列研究包括接受了顺利的白内障超声乳化手术并双侧植入AcrySof®IQPanOptix®IOL的成年患者。远未矫正视力和矫正视力，中间,在术前和术后1个月和6个月的随访检查中测量了近距离.光现象的速率，术后需要近距离和远距离眼镜，和PCO也被记录。
■我们纳入了82例患者的164只眼，男女比例为38（46.3％）至44（53.7％），平均（标准差[SD]）年龄为52.37（7.62）岁。在1个月和6个月的随访检查中，所有距离的双眼视力与术前值相比均有统计学上的显着改善（均P<0.001），除了6个月时右眼矫正近视力(P>0.05)。我们还发现，与一个月随访时相比，在六个月随访时，双眼在所有距离上的术后视力均有显着改善（均P<0.05）。除右眼矫正近视力外(P>0.05)。在术后6个月的随访中，82例患者中有12例（14.6％）报告了光现象。82例患者中有5例（6.1％）和8例（9.8％）报告使用眼镜进行远距离和近距离，分别。此外,在164只被收录的眼睛中，有19只(11.6%)开发了PCO，尽管在6个月时没有临床意义。
■建议使用AcrySof®IQPanOptix®IOL型号TFNT00，鉴于其在所有视觉范围内的出色性能，高的眼镜独立性，和良好的安全性。未来的比较研究需要更长的随访时间，以验证其性能优于其他可用的多焦点IOL。
